BDWM
ABMD

Brewin Dolphin Wealth Management’s Abiomed Inc ABMD Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$19K Hold
75
– – ﹤0.01% 244
2022
Q1 		$25K Hold
75
– – ﹤0.01% 234
2021
Q4 		$27K Hold
75
– – ﹤0.01% 239
2021
Q3 		$24.4K Hold
75
– – ﹤0.01% 250
2021
Q2 		$23.4K Hold
75
– – ﹤0.01% 254
2021
Q1 		$23.9K Buy
+75
New +$24K ﹤0.01% 243

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brewin Dolphin Wealth Management's ABMD Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Abiomed Inc (ABMD) position steady in Q2 2022 at 75 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

Brewin Dolphin Wealth Management first reported a position in ABMD in Q1 2021 and has held it in 6 quarters since. The position peaked at $27K in Q4 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Brewin Dolphin Wealth Management held 75 shares of Abiomed Inc worth $19K as of Q2 2022.
  • Brewin Dolphin Wealth Management left its Abiomed Inc share count unchanged in Q2 2022.
  • Abiomed Inc made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #244 holding.
  • Brewin Dolphin Wealth Management first reported a position in Abiomed Inc in Q1 2021 and has held it in 6 quarters since.
  • Brewin Dolphin Wealth Management's Abiomed Inc position peaked at $27K in Q4 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.